We Prioritize
Women in Corporate

Most women do not have a hormone problem.
They have a biological priority problem.

Board weeks, travel, deadlines and caregiving all place real demands on your biology. It responds by making trade-offs. We help you see which ones it is making, and change one thing at a time.

The problem

You have tried the obvious things.
Something still does not fit.

Perhaps you have eaten differently, exercised harder, taken supplements that promised balance, improved your sleep, or read late into the night looking for an answer that finally made sense. Yet energy is not what it was, sleep has become unpredictable, and your concentration is not as sharp. You begin to wonder whether this is simply what getting older feels like, or whether your body is failing you.

What if neither is true, and your body is doing exactly what it was designed to do?

800M+Women in perimenopause and menopause globally
73%Of women with hormonal symptoms receive no specialist care
7 yrsAverage delay to a correct diagnosis for hormonal conditions
Higher risk of anxiety and depression in women compared with men
The biological hierarchy of priorities
Safety and survivalFunded first, always
Energy productionGlucose, fuel, alertness
Hormonal adaptationCycle, mood, thermoregulation
Repair and regenerationTissue, bone, immune recovery
PerformanceFocus, drive, stamina. Funded last.
Performance is the last thing your biology funds

Every second, your biology decides where to invest the resources it has. Should it focus on immediate survival, defend against inflammation, conserve energy, support reproduction, or repair damaged tissue? These decisions happen long before you notice a symptom, long before a blood test changes, and long before any diagnosis appears.

When demand exceeds capacity, your body does not simply break. It begins making trade-offs. Energy that might support tissue repair is redirected toward maintaining blood glucose. Resources that normally support reproductive hormones go to more immediate demands. Digestion slows. Sleep lightens. Recovery takes longer.

This is not a defective body. It is an adaptive one. The difficulty is that an adaptation which helps across one hard week becomes a burden when it is held for months.

The body rarely works against you. It works for your survival, even when that adaptation eventually becomes the source of your symptoms.

Understanding what your biology is trying to protect
How working life enters the equation

The load is real.
So is the adaptation to it.

Each of these is a normal biological response to a genuine demand. The difficulty is not that your body reacts. It is that a short term reaction, held long enough, starts to cost something.

LoadAdaptive intentWhat it can look like over time
Sustained pressureMobilisation, helpful if time limited Altered cycle patterns, premenstrual sensitivity, anxiety, migraine, fragmented sleep
Short sleep and late nightsShort term wakefulness Appetite and glucose volatility, mood and concentration change, night sweat distress
Travel and shifting hoursSchedule adaptation Cycle irregularity, glucose dysregulation, low mood. Often reversible with schedule recovery.
Meals taken around meetingsPostprandial energy handling Afternoon energy collapse, cravings, and longer term metabolic load
Caregiving with low supportProtective vigilance Sleep, mood and pain amplification, and a plan that becomes hard to sustain
Alcohol used to wind downNo necessary biological accomplishment Sleep architecture disruption, hot flush trigger, migraine, metabolic burden
Burden above recoverySignals a need for adaptation Symptoms cluster across several systems with no single hormone explanation

What this is not

  • Not a claim that your work is making you ill.
  • Not a reason to attribute every symptom to stress.
  • Ambition, exercise and demanding work are not the problem. The mismatch with recovery is.

Why the same quarter lands differently

  • Two women can carry an identical workload and feel entirely different.
  • Life stage changes what biology is prioritising, and genetic sensitivity changes how a given load is handled.
  • Recovery capacity differs between people, and it is not fixed.
Our approach

Most approaches ask which hormone is low.
We ask a different question.

Meaningful understanding does not come from one test. It emerges when several sources of information are interpreted together, and once they are, one question becomes answerable: what is your biology trying to protect today?

Static reporting
“COMT variant present”

A conventional report stops at a fixed risk label and leaves you, and your care team, without anything biologically actionable. It tells you something about your genome but nothing about your Tuesday.

Cellestra interpretation
“Reduced oestrogen clearance capacity under stress”

The same genomic signal becomes a dynamic influence, clarifying when vulnerability actually expresses itself, what raises or lowers it, and which single change is worth making first.

Cellestra Biological Priority Engine™

Six sources, interpreted together.

No single test tells the story. The pattern between them does.

01

Genetic sensitivity

Inherited tendencies influencing how your body responds to nutrition, stress, inflammation, detoxification, hormones and environmental factors.

02

Blood biomarkers

Objective measures giving a snapshot of your current physiological state, always read with their units, timing and reference interval attached.

03

Clinical symptoms

Your lived experience. Symptoms are not interruptions to the story. They are part of the story.

04

Life stage

Whether you are cycling, planning pregnancy, postpartum, perimenopausal or postmenopausal, biology changes its priorities across stages.

05

Lifestyle

Sleep patterns, nutrition, movement, recovery, relationships, daily routines and environmental exposures. These influence biology every day.

06

Wearables and daily physiology

Heart rate variability, activity, sleep timing, recovery and circadian rhythm, giving context between clinic visits.

What we do not claim

  • Association is not proof of causation.
  • Hormone levels cannot be inferred from symptoms alone.
  • No food, and no supplement, balances hormones on its own.
  • Lifestyle supports health. It is not a guarantee that hormones will normalise.

What makes an action worth taking

  • Small enough to repeat on your worst week, not only your best.
  • Specific enough that you know by evening whether you did it.
  • One primary change at a time, so we can tell what did the work.
  • Reviewed after a defined interval, then kept, adjusted or dropped.
The science · Neuro-Hormonal Cascade

The cascade begins in the brain,
not in the ovary.

For women carrying high cognitive and emotional load, the first domino is neural demand: threat appraisal, decision volume, and how safe the nervous system judges the situation to be. Everything downstream inherits that setting.

Tier 1

Cortico-limbic context

Threat appraisal, reward and salience, cognitive load, and relational safety.

We never infer trauma, personality or behaviour from a genotype.
Tier 2

Hypothalamic integration

Where stress signalling, energy availability, cycle pattern and the body clock are reconciled.

Hypothalamic suppression is a diagnosis of exclusion.
Tier 3

HPA rhythm and buffering

The primary amplifier. Cortisol pattern, feedback sensitivity, and remaining recovery capacity.

We do not diagnose adrenal fatigue. It is not a clinical entity.
Tier 4

Inflammatory tone

A parallel amplifier shaped by sleep debt, adiposity, illness and environmental exposure.

Nonspecific markers require a cause assessment, not a label.
Tier 5

Structural consequence

Bone, muscle and connective tissue, cardiometabolic terrain, and urogenital capacity.

Clinical thresholds always override any wellness score.
Integrated Hormonal Atlas · neural arms

Three mechanisms behind fog, flatness and 3 a.m.

These are the pathways most often mistaken for burnout, for a personality change, or for simply getting older.

Neurosteroid and GABA tone

Progesterone converts to allopregnanolone, which modulates the GABA-A receptor, the nervous system's principal calming input. When ovulation becomes inconsistent, that calming input becomes inconsistent with it.

Often felt as evening agitation, a mind that will not settle, and waking at three in the morning before a demanding day.

Dopaminergic architecture

Oestrogen and testosterone support dopaminergic tone, receptor density and reward signalling. As they withdraw, drive and reward can flatten independently of anything recognised as classical depression.

Often felt as motivational fatigue, work that used to feel energising now feeling effortful, and satisfaction that does not quite arrive.

Serotonergic support

Oestrogen influences serotonin synthesis and turnover. Its decline can produce a serotonergic insufficiency that shows up first in sleep architecture, before it is ever noticed as mood.

Often felt as fragmented sleep, lower frustration tolerance, and mood that moves faster than the situation warrants.

Why this matters for demanding work

  • The hormonal substrate of women's mental health often goes unexamined entirely.
  • These mechanisms describe neural demand and capacity. They are not a character trait, a performance rating, or a reason to step back from ambitious work.
  • Naming a mechanism changes what can be done about it.

The limits we hold to

  • A gene variant is a sensitivity modifier only. It never establishes a diagnosis, a prognosis or a risk state on its own.
  • Premenstrual dysphoric disorder requires a prospective symptom pattern, not a single questionnaire and not a genetic result.
  • Mental health symptoms need clinical assessment. This work sits alongside that care, never in place of it.
Your journey

The same career, carried by
six different bodies.

Chronological age is context, not a stage. Position is inferred from your cycle pattern, bleeding history and time since a final menstrual period, then interpreted alongside symptoms, medications and laboratory context. Each stage carries a distinct biology, a distinct vulnerability, and a distinct set of demands from your working life.

Stage 01 · Early reproductive

Cycles consolidate while the career is being built

Ovulation settles into a predictable pattern and ovarian reserve is usually high. This is also when working hours are longest, travel begins, and under-fuelling is most likely to be mistaken for discipline.

The biology
  • Coordinated follicular signalling with a mid-cycle surge and luteal progesterone
  • Predictable oestradiol rise; ovarian reserve usually high
  • Bone, vascular and neural support running at full strength
The corporate context
  • Long hours, first serious travel, proving-ground years
  • Exercise often increases while eating becomes less regular
  • Symptoms are easy to dismiss as the cost of ambition
What we watch for
  • Premenstrual mood and pain that interferes with function
  • Low energy availability suppressing the axis, which is reversible
  • Iron loss from heavy bleeding, which mimics hormonal fatigue
Where we usually start
  • A cycle and symptom record across three to six cycles
  • Iron status assessed properly rather than supplemented blindly
  • Fuelling matched to training load, and a consistent sleep window
Stage 02 · Peak reproductive

A stable personal signature, and the fullest decisions

Cycles reach their most predictable form just as career and family decisions often arrive together. Conditions that were quietly present frequently declare themselves here.

The biology
  • Robust follicle recruitment, ovulation and luteal feedback
  • Cyclic oestradiol and progesterone with a stable personal rhythm
  • Androgen and insulin context shapes how the phenotype expresses
The corporate context
  • Senior individual contributor or first management responsibility
  • Fertility decisions weighed against promotion timing
  • Recovery is the first thing sacrificed when workload rises
What we watch for
  • Polycystic ovary syndrome and endometriosis surfacing or worsening
  • Cycle-linked migraine and mood sensitivity
  • Insulin and sex hormone binding globulin shifting the androgen picture
Where we usually start
  • Metabolic foundation through meal architecture and movement
  • Fertility context documented before it becomes urgent
  • Pain investigated rather than accepted as the price of being hormonal
Stage 03 · Late reproductive

Subtle change, arriving during the caregiving squeeze

Cycles remain broadly regular while reserve quietly declines and luteal progesterone becomes less reliable. This often coincides with responsibility for both children and ageing parents.

The biology
  • Cycles may shorten; early follicular signalling becomes more variable
  • Oestradiol often preserved, sometimes intermittently high
  • Progesterone exposure becomes vulnerable as ovulation varies
The corporate context
  • Leadership responsibility alongside caregiving on two fronts
  • Protected time disappears first, and recovery capacity narrows
  • Sleep is interrupted by others as often as by biology
What we watch for
  • Heavier flow, breast tenderness and worsening migraine
  • Sleep and mood sensitivity emerging before cycles look abnormal
  • Structural causes of bleeding, which need evaluation rather than assumption
Where we usually start
  • Sleep architecture and a defended wind-down
  • Progressive strength work, which begins to matter more from here
  • Relational support treated as a clinical variable, not a soft one
Stage 04 · Early menopausal transition

The stage most often mistaken for burnout

Cycle length begins to differ persistently from your own baseline. Oestradiol swings and anovulatory cycles reduce progesterone, and with it the allopregnanolone that quiets the nervous system. It typically arrives at peak career responsibility.

The biology
  • Persistent cycle-length difference of seven days or more from your baseline
  • Oestradiol swings high and low; more cycles without ovulation
  • Falling progesterone reduces GABA-A calming input
The corporate context
  • Peak responsibility, board exposure and highest cognitive load
  • Anxiety and fog are frequently attributed to the job rather than to biology
  • Many women quietly question whether they can continue at this level
What we watch for
  • New or worsening anxiety, insomnia and cognitive complaints
  • Vasomotor symptoms beginning, and bleeding changes needing evaluation
  • Thyroid disease and other mimics, which must be excluded rather than assumed
Where we usually start
  • Circadian anchoring, since timing is the cheapest lever available
  • Recovery blocks and workload pacing built into the calendar
  • An informed conversation with your clinician about all available options
Stage 05 · Late menopausal transition

Vasomotor burden meets maximum visibility

Intervals without bleeding lengthen beyond sixty days and oestradiol trends down after large excursions. Hot flushes and night sweats become the dominant symptom, often during the years of greatest external exposure.

The biology
  • Marked cycle variability with infrequent ovulation
  • Large oestradiol excursions followed by decline
  • The thermoregulatory network narrows the comfortable temperature range
The corporate context
  • Senior leadership, presenting, travelling, and warm rooms
  • Night sweats fragment sleep before the days that matter most
  • Managing visible symptoms becomes its own cognitive load
What we watch for
  • Frequency, severity and sleep interference of vasomotor symptoms
  • Heavy or skipped bleeding, which requires clinical evaluation
  • Alcohol, heat and stress acting as individual triggers
Where we usually start
  • Trigger mapping across heat, alcohol, stress, sleep and meals
  • Thermal environment at night, within comfort and safety
  • Clinical options discussed openly, including therapies we do not provide
Stage 06 · Postmenopause

A new steady state, and a longer horizon

Twelve months without bleeding marks the milestone. Oestradiol and progesterone remain low, and the early years after carry the fastest change in bone and cardiometabolic terrain. The work shifts from symptom management to protecting capacity for decades.

The biology
  • A stable low ovarian steroid environment
  • Bone loss and cardiometabolic redistribution accelerate early
  • Local tissue conversion becomes relatively more important
The corporate context
  • Executive and board roles, mentorship, and often the most influence
  • Symptoms may settle while long-term risk quietly rises
  • Functional capacity, not symptom relief, becomes the real objective
What we watch for
  • Bone and fracture risk, and muscle loss
  • Lipids, blood pressure and glucose as cardiometabolic terrain shifts
  • Genitourinary symptoms, which often progress untreated and need not
Where we usually start
  • Resistance training, with impact and balance work where appropriate
  • Protein and nutrient adequacy assessed before any supplement
  • Clinical bone and cardiovascular pathways followed properly

Any bleeding after menopause is never a normal transition and always requires clinical evaluation. Stage position is a hypothesis with a stated confidence, never a label, and it is always reviewed by your physician.

The programme

One question, asked properly,
changes what you change.

Rather than changing everything at once, we find where one carefully chosen action has the greatest opportunity to support what your biology is already prioritising. Because meaningful change is rarely the result of doing more. More often it is the result of doing the right thing, at the right time, for the right biological reason.

Step 01

Profile

A complete signature built from genetics, blood biomarkers, symptoms and wearable data. Not a single snapshot, but your living hormonal system.

Step 02

Physician review

All results are published to a governed physician portal. Your trained physician reviews the intelligence and authors your recommendations.

Step 03

One small action

One feasible action with its dose and cue defined, a short trial window, and an agreed measure decided before anything begins.

Step 04

Observe and recalibrate

Reviewed after a defined interval, then kept, progressed, adjusted or stopped. The plan adapts across every lifecycle transition.

The Daily Rhythm Model

A time architecture, not a productivity schedule.

Anchors are set relative to your own waking time and your real constraints, never to a universal clock. There is no mandatory six o'clock start and no mandatory breakfast.

Wake anchor

A consistent window

Outdoor light within one to two hours of waking, for ten to thirty minutes as conditions allow.

Steadies sleep and wake timing.
First meal

Protein and fibre

Built around your hunger, goals and medication rather than an imposed hour.

Satiety and steadier energy.
Caffeine

An earlier cut-off

Moved earlier or reduced when sleep or anxiety is sensitive. Genes alone cannot set the time.

Faster sleep onset, fewer awakenings.
Midday

Light and movement

A short outdoor break, or a five to twenty minute walk after a suitable meal.

Alertness and post-meal energy.
Between blocks

Two minutes of breath

Comfortable paced breathing with a longer exhale, before or after high load work.

Stop if dizzy or distressed.
Sedentary work

Interrupt the sitting

Stand, stretch or walk briefly every thirty to ninety minutes where feasible.

Circulation and glucose handling.
Evening

A digital sunset

Dimmer overhead light and a notification boundary one to three hours before sleep.

Night mode alone may not be enough.
Wind-down

Thirty to sixty minutes

Reading, stretching, journaling, prayer or a body scan. Your choice, not a prescription.

Sleep onset and perceived recovery.
The wider protocol

Five domains, and where each one stops.

A protocol is only as trustworthy as the boundary drawn around it. Each domain carries its own evidence standard and its own explicit limit.

Movement

Progressive resistance work two to three days a week for muscle, bone and insulin sensitivity, aerobic activity accumulated across the week, plus balance and impact loading where appropriate.

Recovery days are part of the plan, not a failure of it. Clinical clearance where injury, pregnancy, bone or cardiac factors apply.

Food

Protein and fibre at each meal, colour and diversity, iron paired with vitamin C where need is shown, and hydration matched to climate and activity.

No detox claims, no hormone flushing, no moral language. Broad exclusions only with real evidence, protecting nutritional adequacy.

Mind, body and nature

Paced breathing, progressive muscle relaxation, body scan, journaling, creative recovery, yoga or tai chi, nature walks and time in green or blue space.

Trauma sensitivity respected throughout. Earthing is offered as optional and exploratory on preliminary evidence, never as treatment.

Supplements

Considered only when diet, laboratory results, a diagnosed condition or your clinician supports it, with interaction screening and a defined endpoint before starting.

Never chosen from a genotype. Iron is never dosed blind. Botanicals carry real interaction and pregnancy restrictions.

Staying with you

Measured against your own baseline,
and nobody else's.

Hormonal health is not a problem you solve once. It is a system you keep reading as it changes. Every recommendation carries a measurable endpoint and a review interval, and a trial that does not help still tells us something worth knowing.

What we track

  • Sleep regularity and sleep efficiency
  • Energy stability across the day
  • Perceived recovery, with heart rate variability as context
  • Symptom interference with work and life
  • Cycle pattern, where relevant
  • Quality of life over months, not days

How we read it

  • Against your personal baseline, never a population average.
  • Outcomes, adherence and context are read together.
  • Biomarkers only when they are clinically relevant.
  • Device limits are acknowledged. No single wearable score decides anything.
  • Plan burden is itself monitored. If it stops being manageable, we reduce it.

Four ways a trial can end

  • Beneficial. We continue it, or progress it carefully.
  • Unclear. We modify a single variable and run it again.
  • No benefit. We stop and reconsider, rather than stacking more on top.
  • Worse, or a red flag. We stop and move to clinical evaluation.
Review happens on a cadence, not on a hunch
IntervalFocusWhat is compared
WeeklyRhythm and burden Sleep regularity and efficiency, energy stability, symptom interference, and how manageable the plan still feels
Per cyclePattern completeness Cycle length, bleeding, variability and skipped intervals, read across three to six cycles rather than one
Four to twelve weeksFunction and strength A functional test or training progression, on a standardised protocol so the comparison means something
Monthly or quarterlyWhole person Quality of life, and biomarkers only at a clinically appropriate interval defined by your physician

Every insight carries

  • What is observed, and why it may matter.
  • The evidence used, and the alternatives that must be excluded.
  • A confidence level, stated honestly.
  • A safe next action, a monitoring endpoint, and an escalation rule.

Confidence, stated honestly

  • Confidence is reported as low, moderate or high, and never implied by a confident tone of voice.
  • High confidence requires at least two independent lines of evidence that are not genetic.
  • Where data conflicts, we show the contradiction and lower the confidence rather than forcing a fit.
  • Where the picture is incomplete, we ask for what is missing instead of guessing.
Governance and privacy

The safeguards matter
as much as the insight.

Precision work on genomic and reproductive data only earns trust if the boundaries are explicit, technically enforced, and stated before anyone signs up.

Your data, plainly

  • Genomic data is never used for insurance underwriting or employer disclosure.
  • Your employer does not receive your results.
  • Consent is granular, and export and deletion are available to you.
  • Reproductive and genomic data are treated as highly sensitive throughout.

Where clinical care takes over

  • Red flags override any wellness recommendation and are never buried in a score.
  • Persistent or severe symptoms need assessment.
  • Any bleeding after menopause requires evaluation.
  • Urgent symptoms require urgent care.
  • Treatment decisions remain clinician guided.

What the platform is

  • General wellness support and clinician decision support.
  • Not autonomous diagnosis, and not treatment.
  • Outputs are non-diagnostic capacity estimates rather than diagnoses.
  • Clinician approval is required before any diagnostic implication, test, supplement or treatment.
Controls that sit behind every output

Human oversight

Clinician sign-off is required before any diagnostic implication, and every override is recorded with its reason.

Claim discipline

Each output is labelled as an observation, association, hypothesis, wellness action, clinical question or escalation, which prevents a hypothesis drifting into fact.

Fairness and ancestry

Performance and uncertainty are measured across ancestry, age and stage, and unsupported genetic inference is suppressed rather than shown.

Evidence versioning

Every rule cites its sources, evidence grade and review date, so outdated logic is retired rather than quietly carried forward.

For organisations

The hidden hormonal cost of
losing experienced women.

Attrition, absence and quiet performance decline often have a biological substrate that no engagement survey will surface. Cellestra partners with organisations to address it properly, through clinicians, with individual privacy intact.

Who it is for

  • HR leaders and people teams
  • Employee assistance providers
  • Employee wellness and benefits programmes
  • Organisations with senior women in demanding roles

How it is delivered

  • Commercial agreement on institutional terms and rates
  • Your physicians onboarded and certified on the platform
  • Genetic test logistics handled end to end
  • Results published to the physician portal for review
  • Precision plans delivered by your trained physician

What you receive, and do not

  • Reporting is aggregate and never individually identifying.
  • Individual results stay between a woman and her clinician.
  • No genomic data is shared with the employer under any circumstance.
  • Participation is voluntary and consent is granular.
Begin with one question

What is your biology
trying to protect today?

Before we recommend change, we first seek understanding. Every meaningful intervention begins with the same question, and once it is answered, the rest tends to follow.

What you can expect

  • A profile built from your genetics, biomarkers, symptoms and daily context.
  • An interpretation of what your biology appears to be prioritising now.
  • One well chosen action, with a defined trial window.
  • A review, and then the next decision made with better information.

Who gets in touch

  • Women seeking hormonal clarity for themselves.
  • Physicians and clinicians looking for decision support.
  • Corporate and HR leaders building a women's health programme.
  • Healthcare institutions and research collaborators.

Start the conversation

Write to us and we will arrange a consultation tailored to your context, whether that is for yourself or for your organisation.

support@cellestra.life

Cellestra Biosciences Ltd
www.cellestra.life

Evidence framing. Informed by WHO physical activity guidance and by The Menopause Society patient and nonhormone therapy resources. Lifestyle supports health, but specific symptom treatment may require clinical therapy. Not a diagnosis and not individual medical advice.